Common stock, $0.01 par value
- Symbol
- AGPU
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 8.01, 9.01 · 8-K
Axe Compute Inc.
AGPUNASDAQEQUITYCurrent
Other Events
Item 8.01. Other Events. On July 22, 2026, Axe Compute Inc. (the “Company”) issued a press release announcing that the Company has secured more than $1.3 billion in new customer contracts across the United States and Europe through the Axe Compute Build program. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.…
Press release in this filing
Axe Compute Secures Over $1.3 Billion in Global AI Infrastructure Customer Contracts →Company context
We are a knowledge-driven company focused on applying artificial intelligence (“AI”) to support the discovery and development of optimal cancer therapies, which can ultimately lead to more effective treatments and improved patient outcomes. We use AI and our proprietary biobank of 150,000 tumor samples, categorized by tumor type, to provide actionable insights about drug compounds to improve the drug discovery process and increase the probability of drug compound success. We also create and develop tumor-specific 3D cell culture models mimicking the physiological environment of human tissue, enabling better-informed decision-making during drug development. Our suite of solutions supports oncology drug development from early discovery to clinical trials.
Current securities
Registered securities in this filing
Axe Compute Inc. · 8-K · Filed 2026-07-22
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item 8.01. Other Events.
On July 22, 2026, Axe Compute Inc. (the “Company”) issued a press release announcing that the Company has secured more than $1.3 billion in new customer contracts across the United States and Europe through the Axe Compute Build program. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information set forth in this Item 8.01, including Exhibit 99.1, is being “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is hereby incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, to the extent not superseded by information contained therein.